SCHEMBL22889253

SCHEMBL22889253

c1ccc(-c2ccccc2-c2nc(-c3ccc(-c4cc5ccccc5c5ccccc45)cc3)nc(-c3cccc4c3oc3ccccc34)n2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.46
MAPT P10636 8/20 0.40
ALDH1A1 P00352 7/20 0.39
KDM4E B2RXH2 6/20 0.39
POLB P06746 2/20 0.39
CYP11B1 P15538 1/20 0.39
NPSR1 Q6W5P4 1/20 0.38
GGPS1 O95749 1/20 0.38
TSHR P16473 4/20 0.37
HPGD P15428 3/20 0.37
HSD17B10 Q99714 3/20 0.37
MAPK1 P28482 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
TP53 P04637 1/20 0.37
NFKB1 P19838 1/20 0.37
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37
ATM Q13315 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22889384 0.96 ALOX5 (0.47) ALOX5MAPTALDH1A1KDM4EPOLB
SCHEMBL27340090 0.95 ALOX5 (0.51) ALOX5MAPTALDH1A1KDM4EPOLB
SCHEMBL22889395 0.95 ALOX5 (0.50) ALOX5MAPTALDH1A1KDM4EPOLB
SCHEMBL22889330 0.94 ALOX5 (0.45) ALOX5MAPTALDH1A1KDM4EPOLB
SCHEMBL22888880 0.94 ALOX5 (0.45) ALOX5MAPTALDH1A1KDM4EPOLB
SCHEMBL22889104 0.94 ALOX5 (0.45) ALOX5MAPTALDH1A1KDM4EPOLB
SCHEMBL15501708 0.94 ALOX5 (0.50) ALOX5MAPTALDH1A1KDM4EPOLB
SCHEMBL22889320 0.94 ALOX5 (0.47) ALOX5MAPTALDH1A1KDM4EPOLB
SCHEMBL22058587 0.94 ALOX5 (0.50) ALOX5MAPTALDH1A1KDM4EPOLB
SCHEMBL22889250 0.93 ALOX5 (0.47) ALOX5MAPTALDH1A1KDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11765972-B2 Compound and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2023-09-19 US disclosed
US-11765972-B2 Compound and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2023-09-19 US disclosed
US-20210009527-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO.,LTD. (JP) 2021-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210009527-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME OR10J3, RPS4Y1, AR ALOX5 3163/4885MAPT 2178/4885ALDH1A1 1387/4885
US-11765972-B2 Compound and organic electroluminescence device using the same AR, OR10J3, RPS4Y1 ALOX5 3071/4885MAPT 2233/4885ALDH1A1 1441/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.